on MedMira, Inc. (isin : CA58501R1029)
MedMira and Lovell Partner to Expand Distribution of Reveal® G4 HIV Test
MedMira Inc. has announced a partnership with Lovell Government Services to improve access to its Reveal® G4 HIV-1/2 rapid test across federal healthcare systems. The partnership targets the Veterans Health Administration, Military Health System, and Indian Health Service. Lovell will serve as MedMira's Service-Disabled Veteran-Owned Small Business vendor through federal contracts.
The Reveal® G4 HIV test is recognized for its speed and accuracy, built on MedMira's Rapid Vertical Flow Technology. It is designed to deliver immediate results without fading, avoiding issues like false negatives due to the prozone effect, common in traditional tests. It is available in three formats suitable for various healthcare settings.
Products are accessible through the Department of Veterans Affairs' Federal Supply Schedule, GSA Advantage, and the Department of Defense's contract vehicles, facilitating streamlined procurement processes.
R. P.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all MedMira, Inc. news